SHARE FOR DEBT SETTLEMENT
MYDECINE INNOVATIONS GROUP INC. ANNOUNCES SHARE FOR DEBT SETTLEMENT VANCOUVER, BC – (9 April 2024) Mydecine Innovations Group Inc. (CSE: MYCO) (AQSE: MYIG) (FSE: 0NFA) (OTC: MYCOF) (the “Company” or “Mydecine”) announces that it has entered into debt settlement agreements (the “Settlement Agreements”) to fully settle outstanding debts owed to two creditors (the “Creditors”) for corporate back office services rendered and an unpaid loan. Pursuant to the Settlement Agreements, the Company has agreed to issue an aggregate of 3,628,208 common shares (“Shares”) at a deemed price of $0.